(Q38010463)

English

Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials.

scientific article published on October 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

V Eleftheriadou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

M E Whitton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

J M Batchelor

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

J C Ravenscroft

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

1 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

167

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

804-814

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Guidelines for designing and reporting clinical trials in vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

OMERACT: an international initiative to improve outcome measurement in rheumatology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Avoidable waste in the production and reporting of research evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Tacalcitol and narrow-band phototherapy in patients with vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

L-phenylalanine and UVA irradiation in the treatment of vitiligo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Clinical observation on the effect of Zengse Pill in treating patients with vitiligo of qi-stagnancy and blood-stasis syndrome type

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Scoring systems in dermatology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11056.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2012.11056.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591025%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38010463&oldid=2135934208"